Patents by Inventor Huiling Wu

Huiling Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MOBILE TERMINAL AND POWER CONSUMPTION DETECTION METHOD OF MOBILE TERMINAL
    Publication number: 20240319776
    Abstract: Disclosed are a mobile terminal and a power consumption detection method of the mobile terminal, the mobile terminal including: a power consumption measurement circuit; an application processor configured to transmit a detection command for detecting power consumption data respectively corresponding to at least one hardware module of a plurality of hardware modules of the mobile terminal; and a microprocessor configured to acquire the power consumption data corresponding to the at least one hardware module through the power consumption measurement circuit, based on the detection command received from the application processor.
    Type: Application
    Filed: March 20, 2024
    Publication date: September 26, 2024
    Applicant: Samsung Electronics Co., Ltd.
    Inventors: Huiling WU, Yong Peng
  • Antibodies binding to human IL-4R, preparation method therefor and use thereof
    Patent number: 11667717
    Abstract: Disclosed are antibodies binding to human IL-4R, having identical variable regions and different constant regions, wherein the variable regions can specifically bind to human IL-4R, and the constant regions affect the activity of the whole antibody through an amino acid site mutation. The above-mentioned antibodies can be used to treat diseases related to IL-4R overexpression, such as atopic dermatitis, asthma, etc., and thus possesses good clinical application prospects.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: June 6, 2023
    Assignee: SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
    Inventors: Jie Zhao, Liangfeng Jiang, Chen Chen, Huiling Wu, Yuping Huang, Haomin Huang, Zhenping Zhu
  • ANTIBODIES BINDING TO HUMAN IL-4R, PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20210206861
    Abstract: Disclosed are antibodies binding to human IL-4R, having identical variable regions and different constant regions, wherein the variable regions can specifically bind to human IL-4R, and the constant regions affect the activity of the whole antibody through an amino acid site mutation. The above-mentioned antibodies can be used to treat diseases related to IL-4R overexpression, such as atopic dermatitis, asthma, etc., and thus possesses good clinical application prospects.
    Type: Application
    Filed: August 20, 2019
    Publication date: July 8, 2021
    Inventors: Jie ZHAO, Liangfeng JIANG, Chen CHEN, Huiling WU, Yuping HUANG, Haomin HUANG, Zhenping ZHU
  • Vaccine and uses thereof
    Publication number: 20150132302
    Abstract: The present disclosure provides immunogenic compositions, such as vaccines, including DNA vaccines, and uses thereof, e.g., to suppress or prevent an immune response and/or to treat or prevent an autoimmune disease.
    Type: Application
    Filed: May 1, 2013
    Publication date: May 14, 2015
    Inventors: Stephen Alexander, Yuan Min Wang, Guoping Zheng, Huiling Wu, David Charles Hamlyn Harris, Yiping Wang
  • Treatment for renal disease
    Publication number: 20060194752
    Abstract: Methods for treating or preventing renal disease or inducing passive immunity against renal disease by administering polynucleotides encoding MCP-1 or both MCP-1 and RANTES are provided. Compositions containing polynucleotides encoding MCP-1 or both MCP-1 and RANTES are also provided.
    Type: Application
    Filed: June 7, 2005
    Publication date: August 31, 2006
    Applicant: The Children's Hospital at Westmead Sydney West Area Health Service
    Inventors: Stephen Alexander, David Harris, Yiping Wang, Huiling Wu, Guoping Zheng